Uncovering the Peptide-Binding Specificities of HLA-C: A General Strategy To Determine the Specificity of Any MHC Class I Molecule
暂无分享,去创建一个
Morten Nielsen | Søren Buus | Mikkel Harndahl | Anette Stryhn | Lise Lotte Nielsen | M. Nielsen | S. Buus | M. Harndahl | F. Lemonnier | A. Stryhn | M. Rasmussen | L. L. Nielsen | Michael Rasmussen | Rachid Boucherma | François A Lemonnier | Rachid Boucherma
[1] O. Lund,et al. NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.
[2] S Brunak,et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. , 2003, Tissue antigens.
[3] U. Hobohm,et al. Selection of representative protein data sets , 1992, Protein science : a publication of the Protein Society.
[4] O. Mandelboim,et al. Self and viral peptides can initiate lysis by autologous natural killer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] Don C. Wiley,et al. Structure of Human Histocompatibility Leukocyte Antigen (Hla)-Cw4, a Ligand for the Kir2d Natural Killer Cell Inhibitory Receptor , 1999, The Journal of experimental medicine.
[6] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[7] Soung Hie Kim,et al. An Artificial Neural Network Approach , 1993 .
[8] Morten Nielsen,et al. Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion , 2012, Nucleic Acids Res..
[9] C. Sylvester-Hvid,et al. Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds , 2001, European journal of immunology.
[10] M. Altfeld,et al. Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection. , 2011, Trends in immunology.
[11] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[12] Søren Buus,et al. Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. , 2011, Journal of immunological methods.
[13] C. Heirman,et al. Identification of New Antigenic Peptide Presented by HLA-Cw7 and Encoded by Several MAGE Genes Using Dendritic Cells Transduced with Lentiviruses 1 , 2004, The Journal of Immunology.
[14] Y. Godet,et al. A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes , 2008, Cancer Immunology, Immunotherapy.
[15] Morten Nielsen,et al. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 , 2008, Nucleic Acids Res..
[16] K. Collins,et al. The emerging role of HLA‐C in HIV‐1 infection , 2011, Immunology.
[17] D. Zipeto,et al. HLA-C and HIV-1: friends or foes? , 2012, Retrovirology.
[18] V. Gnau,et al. Allele-specific peptide ligand motifs of HLA-C molecules. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Carroll,et al. Identification of a major histocompatibility complex class I‐restricted T‐cell epitope in the tumour‐associated antigen, 5T4 , 2006, Immunology.
[20] Bjoern Peters,et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.
[21] D. Lake,et al. Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries , 2004, Immunogenetics.
[22] P. Parham,et al. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.
[23] P. Parham,et al. Review: Immunogenetics of human placentation. , 2012, Placenta.
[24] Jeffrey C. Boyington,et al. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand , 2000, Nature.
[25] S. Robson,et al. Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. , 2010, Placenta.
[26] C. Sylvester-Hvid,et al. One-Pot, Mix-and-Read Peptide-MHC Tetramers , 2008, PloS one.
[27] Søren Buus,et al. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding , 1996, European journal of immunology.
[28] Morten Nielsen,et al. The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype , 2008, Immunogenetics.
[29] H. Sebastian Seung,et al. Query by committee , 1992, COLT '92.
[30] S. Buus,et al. HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 Monochain Transgenic/H-2 Class I Null Mice: Novel Versatile Preclinical Models of Human T Cell Responses , 2013, The Journal of Immunology.
[31] M. Nielsen,et al. Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses against HCMV Proteins IE1 and IE2 , 2014, PloS one.
[32] Morten Nielsen,et al. Peptide‐MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity , 2012, European journal of immunology.
[33] Eric O Long,et al. The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity , 1997, The Journal of experimental medicine.
[34] Morten Nielsen,et al. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.
[35] J J Goedert,et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.
[36] O. Lund,et al. NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.
[37] K. Parker,et al. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Nielsen,et al. Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays , 2009, Journal of biomolecular screening.
[39] Clemencia Pinilla,et al. Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior , 2009, BMC Bioinformatics.
[40] F. Greenwood,et al. Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.
[41] C. Sylvester-Hvid,et al. Purification of correctly oxidized MHC class I heavy‐chain molecules under denaturing conditions: A novel strategy exploiting disulfide assisted protein folding , 2003, Protein science : a publication of the Protein Society.
[42] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[43] Søren Buus,et al. A novel system for continuous protein refolding and on‐line capture by expanded bed adsorption , 2005, Protein science : a publication of the Protein Society.
[44] T. Elliott,et al. Peptide antagonism as a mechanism for NK cell activation , 2010, Proceedings of the National Academy of Sciences.
[45] P. Parham,et al. Chimpanzees Use More Varied Receptors and Ligands Than Humans for Inhibitory Killer Cell Ig-Like Receptor Recognition of the MHC-C1 and MHC-C2 Epitopes1 , 2009, The Journal of Immunology.
[46] O. Lund,et al. MHCcluster, a method for functional clustering of MHC molecules , 2013, Immunogenetics.